Assurant (AIZ)
(Delayed Data from NYSE)
$191.76 USD
+0.06 (0.03%)
Updated Nov 1, 2024 04:00 PM ET
After-Market: $191.80 +0.04 (0.02%) 7:58 PM ET
4-Sell of 5 4
B Value C Growth D Momentum B VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$191.76 USD
+0.06 (0.03%)
Updated Nov 1, 2024 04:00 PM ET
After-Market: $191.80 +0.04 (0.02%) 7:58 PM ET
4-Sell of 5 4
B Value C Growth D Momentum B VGM
Zacks News
AIG Rises 16.4% in Three Months: What's Driving the Stock?
by Zacks Equity Research
AIG's management is working on improving ROCE with the help of cost-curbing efforts, enhancing underwriting profitability and streamlining operations.
Assurant (AIZ) Could Be a Great Choice
by Zacks Equity Research
Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy task. Does Assurant (AIZ) have what it takes? Let's find out.
Here's Why Investors May Consider Betting on Assurant (AIZ) Now
by Zacks Equity Research
Assurant (AIZ) stands to gain from improved Connected Living business, well-diversified business, rise in invested assets, favorable growth estimates and a solid capital position.
Here's Why Investing in Lemonade (LMND) Stock is Prudent Now
by Zacks Equity Research
Lemonade (LMND) stands to gain from growth on premium placed with third-party insurance companies, interest rates on investment balances and improvement in the average policy value.
Here's Why Hold Strategy is Apt for Coinbase Global (COIN)
by Zacks Equity Research
Coinbase Global (COIN) should benefit from an enhanced product suite and reduced operating expenses in the future.
Here's Why Investors Should Hold Cigna (CI) Stock for Now
by Zacks Equity Research
Cigna's (CI) strong Evernorth and Cigna Healthcare segments, growing medical membership and a positive 2023 outlook poise it well for growth.
Is Assurant (AIZ) Stock Outpacing Its Finance Peers This Year?
by Zacks Equity Research
Here is how Assurant (AIZ) and Blackstone Secured Lending Fund (BXSL) have performed compared to their sector so far this year.
Here's Why You Should Retain Prudential Financial (PRU) Stock
by Zacks Equity Research
Prudential Financial (PRU) stands to gain from higher premiums, strategic acquisitions, favorable underwriting results and effective capital deployment.
MetLife (MET) and Lyra Unite to Improve Employee Mental Health
by Zacks Equity Research
MetLife (MET) partners with Lyra to provide employees with mental health solutions and improve their well-being in difficult situations.
Zacks Investment Ideas feature highlights: Assurant, Radian Group, Old Republic International , MetLife and Prudential Financial
by Zacks Equity Research
Assurant, Radian Group, Old Republic International , MetLife and Prudential Financial are part of the Zacks Investment Ideas article.
5 Dividend-Paying Multiline Insurers That Ensure Stable Income
by Tanuka De
Multiline insurers like Assurant Inc. (AIZ), Radian Group Inc. (RDN), Old Republic International Corporation (ORI), MetLife Inc. (MET) and Prudential Financial Inc. (PRU), which have an impressive dividend history, offer a breather amid volatility.
Here's Why You Should Hold American Equity (AEL) Stock for Now
by Zacks Equity Research
AEL 2.0 strategy, strong annuity product sales and an aging U.S. population poise American Equity (AEL) well for growth.
MarketAxess (MKTX) Partners With Investortools for Muni Trading
by Zacks Equity Research
MarketAxess' collaborates with Investortools to integrate its municipal bonds in the Investortools Dealer Network.
Are You Looking for a High-Growth Dividend Stock?
by Zacks Equity Research
Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy task. Does Assurant (AIZ) have what it takes? Let's find out.
Here's Why You Should Hold EverQuote (EVER) in Your Portfolio
by Zacks Equity Research
EverQuote (EVER) stands to gain from the solid performance of automotive and other insurance marketplace verticals and higher consumer traffic.
Radian Group (RDN) Up 26.7% in a Year: Will the Rally Last?
by Zacks Equity Research
Radian Group (RDN) stock rallies on the back of improved persistency and mortgage insurance portfolio, solid capital position as well as effective capital deployment.
MetLife (MET) Launches Pet Health and Wellness App With Microsoft
by Zacks Equity Research
MetLife (MET) launches an enhanced pet insurance app with Microsoft to help pet parents.
3 Value Stocks From the Undervalued Multiline Insurance Industry
by Sushmita Sarker
Leveraging better pricing, increased exposure, technological advancement, improving rate environment, undervalued multiline insurers like AIZ, AIG and RDN are poised to fetch better returns.
Here's Why Investors Should Hold Marsh & McLennan (MMC) Stock
by Zacks Equity Research
Marsh & McLennan (MMC) is currently aided by higher insurance rates, its strong segmental performance and a tactical capital deployment record.
Here's Why Hold Strategy Is Apt for MGIC Investment (MTG)
by Zacks Equity Research
MGIC Investment (MTG) stands to gain from higher insurance in force, favorable loss reserve development, new business rewriting and prudent capital deployment.
Reasons to Buy American International (AIG) Stock Right Now
by Zacks Equity Research
Strong underwriting gains, improving premiums and increased rates poise American International (AIG) well for growth.
Cigna (CI) Inks Deal With CHSS to Enhance Specialty Care
by Zacks Equity Research
Cigna (CI) partners with CarepathRx Health System Solutions to accelerate the delivery of pharmacy care for patients with complex needs.
Why Is Assurant (AIZ) Down 9.1% Since Last Earnings Report?
by Zacks Equity Research
Assurant (AIZ) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
AIZ vs. PUK: Which Stock Is the Better Value Option?
by Zacks Equity Research
AIZ vs. PUK: Which Stock Is the Better Value Option?
MetLife (MET) Unveils Reinsurance Deal With Global Atlantic
by Zacks Equity Research
MetLife (MET) inscribes a deal to transfer risks related to its U.S. retail life insurance and fixed annuity products to Global Atlantic. It also announces a $1 billion buyback capacity increase.